和邦生物 (603077.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(和邦生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
主要指标:
 营业收入(元) 6,813,692,192.924,848,440,513.181,999,261,196.408,824,107,811.826,434,462,278.944,090,613,303.822,394,468,174.84
 营业利润(元) 260,299,739.07245,767,298.4043,612,198.851,541,792,116.141,210,602,688.47729,549,281.19477,206,214.04
 利润总额(元) 259,501,458.70245,320,877.1243,608,602.021,535,965,520.991,209,838,849.38728,835,852.35476,583,819.35
 净利润(元) 195,536,979.04188,048,359.5527,143,210.751,278,699,260.631,014,075,433.12603,141,895.11381,460,623.90
 归属于母公司股东的净利润(元) 221,318,621.02192,269,822.5929,792,564.091,283,243,893.341,019,044,364.44616,531,723.76396,561,190.75
盈利能力:
 销售毛利率(%) 10.7011.1710.1123.2624.0623.6126.10
 销售净利率(%) 2.873.881.3614.4915.7614.7415.93
 净资产收益率(%) 1.151.000.15----
 总资产报酬率ROA(%) 1.151.040.19----
 投入资本回报率ROIC(%) 0.980.850.135.984.722.931.87
营运能力:
 存货周转率(次) 1.371.060.49----
 应收账款周转率(次) 5.594.721.79----
 总资产周转率(次) 0.270.190.08----
偿债能力:
 资产负债率(%) 25.3925.1923.2617.6217.8515.5316.09
 股东权益比率(%) 72.2472.3774.2479.7679.5681.7881.30
 已获利息倍数(倍) 9.0817.3211.25-46.26-169.50-179.9498.48
 流动比率 1.881.962.122.692.903.002.77
 速动比率 0.971.101.091.431.691.842.02
发展能力:
 营业收入增长率(%) 5.8918.53-16.51-32.33-38.68-45.31-22.41
 营业利润增长率(%) -78.50-66.31-90.86-65.59-70.05-76.51-61.21
 税后利润增长率(%) -78.28-68.81-92.49-66.29-70.27-76.60-61.97
 净资产增长率(%) -5.13-2.14-2.602.396.279.7821.75
 总资产增长率(%) 4.4810.586.661.828.086.5921.79

前瞻产业研究院